 | • レポートコード：GIR-107A14574 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子治療製品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子治療製品の種類別市場規模（エクスビボ、インビボ）、用途別市場規模（がん、単発性、感染症、心血管疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子治療製品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bluebird Bio、Sangamo、Spark Therapeutics、Dimension Therapeutics、Avalanche Bio、Celladon、Vical Inc.、Advantagene ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エクスビボ、インビボ ・用途別分析2016年-2026年：がん、単発性、感染症、心血管疾患、その他 ・遺伝子治療製品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子治療製品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子治療製品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子治療製品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子治療製品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gene Therapy Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gene Therapy Products size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Gene Therapy Products market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gene Therapy Products market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ex vivo
In Vivo
Market segment by Application can be divided into
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other
The key market players for global Gene Therapy Products market are listed below:
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Gene Therapy Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gene Therapy Products, with price, sales, revenue and global market share of Gene Therapy Products from 2019 to 2021.
Chapter 3, the Gene Therapy Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gene Therapy Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Gene Therapy Products market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Gene Therapy Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gene Therapy Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gene Therapy Products Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ex vivo
1.2.3 In Vivo
1.3 Market Analysis by Application
1.3.1 Overview: Global Gene Therapy Products Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious disease
1.3.5 Cardiovascular disease
1.3.6 Other
1.4 Global Gene Therapy Products Market Size & Forecast
1.4.1 Global Gene Therapy Products Sales in Value (2016-2026))
1.4.2 Global Gene Therapy Products Sales in Volume (2016-2026)
1.4.3 Global Gene Therapy Products Price by Type (2016-2026) & (US$/Unit)
1.5 Global Gene Therapy Products Production Capacity Analysis
1.5.1 Global Gene Therapy Products Total Production Capacity (2016-2026)
1.5.2 Global Gene Therapy Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Therapy Products Market Drivers
1.6.2 Gene Therapy Products Market Restraints
1.6.3 Gene Therapy Products Trends Analysis
2 Manufacturers Profiles
2.1 Bluebird Bio
2.1.1 Bluebird Bio Details
2.1.2 Bluebird Bio Major Business
2.1.3 Bluebird Bio Gene Therapy Products Product and Services
2.1.4 Bluebird Bio Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Sangamo
2.2.1 Sangamo Details
2.2.2 Sangamo Major Business
2.2.3 Sangamo Gene Therapy Products Product and Services
2.2.4 Sangamo Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Spark Therapeutics
2.3.1 Spark Therapeutics Details
2.3.2 Spark Therapeutics Major Business
2.3.3 Spark Therapeutics Gene Therapy Products Product and Services
2.3.4 Spark Therapeutics Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Dimension Therapeutics
2.4.1 Dimension Therapeutics Details
2.4.2 Dimension Therapeutics Major Business
2.4.3 Dimension Therapeutics Gene Therapy Products Product and Services
2.4.4 Dimension Therapeutics Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Avalanche Bio
2.5.1 Avalanche Bio Details
2.5.2 Avalanche Bio Major Business
2.5.3 Avalanche Bio Gene Therapy Products Product and Services
2.5.4 Avalanche Bio Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Celladon
2.6.1 Celladon Details
2.6.2 Celladon Major Business
2.6.3 Celladon Gene Therapy Products Product and Services
2.6.4 Celladon Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Vical Inc.
2.7.1 Vical Inc. Details
2.7.2 Vical Inc. Major Business
2.7.3 Vical Inc. Gene Therapy Products Product and Services
2.7.4 Vical Inc. Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Advantagene
2.8.1 Advantagene Details
2.8.2 Advantagene Major Business
2.8.3 Advantagene Gene Therapy Products Product and Services
2.8.4 Advantagene Gene Therapy Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Gene Therapy Products Sales by Manufacturer
3.1 Global Gene Therapy Products Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gene Therapy Products Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gene Therapy Products
3.4 Market Concentration Rate
3.4.1 Top 3 Gene Therapy Products Manufacturer Market Share
3.4.2 Top 6 Gene Therapy Products Manufacturer Market Share
3.5 Global Gene Therapy Products Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gene Therapy Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gene Therapy Products Market Size by Region
4.1.1 Global Gene Therapy Products Sales in Volume by Region (2016-2026)
4.1.2 Global Gene Therapy Products Revenue by Region (2016-2026)
4.2 North America Gene Therapy Products Revenue (2016-2026)
4.3 Europe Gene Therapy Products Revenue (2016-2026)
4.4 Asia-Pacific Gene Therapy Products Revenue (2016-2026)
4.5 South America Gene Therapy Products Revenue (2016-2026)
4.6 Middle East and Africa Gene Therapy Products Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gene Therapy Products Sales in Volume by Type (2016-2026)
5.2 Global Gene Therapy Products Revenue by Type (2016-2026)
5.3 Global Gene Therapy Products Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gene Therapy Products Sales in Volume by Application (2016-2026)
6.2 Global Gene Therapy Products Revenue by Application (2016-2026)
6.3 Global Gene Therapy Products Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gene Therapy Products Sales by Type (2016-2026)
7.2 North America Gene Therapy Products Sales by Application (2016-2026)
7.3 North America Gene Therapy Products Market Size by Country
7.3.1 North America Gene Therapy Products Sales in Volume by Country (2016-2026)
7.3.2 North America Gene Therapy Products Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gene Therapy Products Sales by Type (2016-2026)
8.2 Europe Gene Therapy Products Sales by Application (2016-2026)
8.3 Europe Gene Therapy Products Market Size by Country
8.3.1 Europe Gene Therapy Products Sales in Volume by Country (2016-2026)
8.3.2 Europe Gene Therapy Products Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gene Therapy Products Sales by Type (2016-2026)
9.2 Asia-Pacific Gene Therapy Products Sales by Application (2016-2026)
9.3 Asia-Pacific Gene Therapy Products Market Size by Region
9.3.1 Asia-Pacific Gene Therapy Products Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gene Therapy Products Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gene Therapy Products Sales by Type (2016-2026)
10.2 South America Gene Therapy Products Sales by Application (2016-2026)
10.3 South America Gene Therapy Products Market Size by Country
10.3.1 South America Gene Therapy Products Sales in Volume by Country (2016-2026)
10.3.2 South America Gene Therapy Products Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gene Therapy Products Sales by Type (2016-2026)
11.2 Middle East & Africa Gene Therapy Products Sales by Application (2016-2026)
11.3 Middle East & Africa Gene Therapy Products Market Size by Country
11.3.1 Middle East & Africa Gene Therapy Products Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gene Therapy Products Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gene Therapy Products Typical Distributors
12.3 Gene Therapy Products Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Gene Therapy Products Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gene Therapy Products Revenue by Application, (USD Million), 2021-2026
Table 3. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 4. Bluebird Bio Major Business
Table 5. Bluebird Bio Gene Therapy Products Product and Services
Table 6. Bluebird Bio Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sangamo Basic Information, Manufacturing Base and Competitors
Table 8. Sangamo Major Business
Table 9. Sangamo Gene Therapy Products Product and Services
Table 10. Sangamo Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 12. Spark Therapeutics Major Business
Table 13. Spark Therapeutics Gene Therapy Products Product and Services
Table 14. Spark Therapeutics Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Dimension Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. Dimension Therapeutics Major Business
Table 17. Dimension Therapeutics Gene Therapy Products Product and Services
Table 18. Dimension Therapeutics Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Avalanche Bio Basic Information, Manufacturing Base and Competitors
Table 20. Avalanche Bio Major Business
Table 21. Avalanche Bio Gene Therapy Products Product and Services
Table 22. Avalanche Bio Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Celladon Basic Information, Manufacturing Base and Competitors
Table 24. Celladon Major Business
Table 25. Celladon Gene Therapy Products Product and Services
Table 26. Celladon Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Vical Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Vical Inc. Major Business
Table 29. Vical Inc. Gene Therapy Products Product and Services
Table 30. Vical Inc. Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Advantagene Basic Information, Manufacturing Base and Competitors
Table 32. Advantagene Major Business
Table 33. Advantagene Gene Therapy Products Product and Services
Table 34. Advantagene Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Gene Therapy Products Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Gene Therapy Products Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Gene Therapy Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Gene Therapy Products Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Gene Therapy Products Production Site of Key Manufacturer
Table 40. Gene Therapy Products New Entrant and Capacity Expansion Plans
Table 41. Gene Therapy Products Mergers & Acquisitions in the Past Five Years
Table 42. Global Gene Therapy Products Sales by Region (2016-2021e) & (K Units)
Table 43. Global Gene Therapy Products Sales by Region (2021-2026) & (K Units)
Table 44. Global Gene Therapy Products Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Gene Therapy Products Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Gene Therapy Products Sales by Type (2016-2021e) & (K Units)
Table 47. Global Gene Therapy Products Sales by Type (2021-2026) & (K Units)
Table 48. Global Gene Therapy Products Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Gene Therapy Products Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Gene Therapy Products Price by Type (2016-2021e) & (US$/Unit)
Table 51. Global Gene Therapy Products Price by Type (2021-2026) & (US$/Unit)
Table 52. Global Gene Therapy Products Sales by Application (2016-2021e) & (K Units)
Table 53. Global Gene Therapy Products Sales by Application (2021-2026) & (K Units)
Table 54. Global Gene Therapy Products Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Gene Therapy Products Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Gene Therapy Products Price by Application (2016-2021e) & (US$/Unit)
Table 57. Global Gene Therapy Products Price by Application (2021-2026) & (US$/Unit)
Table 58. North America Gene Therapy Products Sales by Country (2016-2021e) & (K Units)
Table 59. North America Gene Therapy Products Sales by Country (2021-2026) & (K Units)
Table 60. North America Gene Therapy Products Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Gene Therapy Products Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Gene Therapy Products Sales by Type (2016-2021e) & (K Units)
Table 63. North America Gene Therapy Products Sales by Type (2021-2026) & (K Units)
Table 64. North America Gene Therapy Products Sales by Application (2016-2021e) & (K Units)
Table 65. North America Gene Therapy Products Sales by Application (2021-2026) & (K Units)
Table 66. Europe Gene Therapy Products Sales by Country (2016-2021e) & (K Units)
Table 67. Europe Gene Therapy Products Sales by Country (2021-2026) & (K Units)
Table 68. Europe Gene Therapy Products Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Gene Therapy Products Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Gene Therapy Products Sales by Type (2016-2021e) & (K Units)
Table 71. Europe Gene Therapy Products Sales by Type (2021-2026) & (K Units)
Table 72. Europe Gene Therapy Products Sales by Application (2016-2021e) & (K Units)
Table 73. Europe Gene Therapy Products Sales by Application (2021-2026) & (K Units)
Table 74. Asia-Pacific Gene Therapy Products Sales by Region (2016-2021e) & (K Units)
Table 75. Asia-Pacific Gene Therapy Products Sales by Region (2021-2026) & (K Units)
Table 76. Asia-Pacific Gene Therapy Products Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Gene Therapy Products Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Gene Therapy Products Sales by Type (2016-2021e) & (K Units)
Table 79. Asia-Pacific Gene Therapy Products Sales by Type (2021-2026) & (K Units)
Table 80. Asia-Pacific Gene Therapy Products Sales by Application (2016-2021e) & (K Units)
Table 81. Asia-Pacific Gene Therapy Products Sales by Application (2021-2026) & (K Units)
Table 82. South America Gene Therapy Products Sales by Country (2016-2021e) & (K Units)
Table 83. South America Gene Therapy Products Sales by Country (2021-2026) & (K Units)
Table 84. South America Gene Therapy Products Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Gene Therapy Products Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Gene Therapy Products Sales by Type (2016-2021e) & (K Units)
Table 87. South America Gene Therapy Products Sales by Type (2021-2026) & (K Units)
Table 88. South America Gene Therapy Products Sales by Application (2016-2021e) & (K Units)
Table 89. South America Gene Therapy Products Sales by Application (2021-2026) & (K Units)
Table 90. Middle East & Africa Gene Therapy Products Sales by Country (2016-2021e) & (K Units)
Table 91. Middle East & Africa Gene Therapy Products Sales by Country (2021-2026) & (K Units)
Table 92. Middle East & Africa Gene Therapy Products Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Gene Therapy Products Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Gene Therapy Products Sales by Type (2016-2021e) & (K Units)
Table 95. Middle East & Africa Gene Therapy Products Sales by Type (2021-2026) & (K Units)
Table 96. Middle East & Africa Gene Therapy Products Sales by Application (2016-2021e) & (K Units)
Table 97. Middle East & Africa Gene Therapy Products Sales by Application (2021-2026) & (K Units)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Gene Therapy Products Typical Distributors
Table 101. Gene Therapy Products Typical Customers
List of Figures
Figure 1. Gene Therapy Products Picture
Figure 2. Global Gene Therapy Products Sales Market Share by Type in 2020
Figure 3. Ex vivo
Figure 4. In Vivo
Figure 5. Global Gene Therapy Products Sales Market Share by Application in 2020
Figure 6. Cancer
Figure 7. Monogenic
Figure 8. Infectious disease
Figure 9. Cardiovascular disease
Figure 10. Other
Figure 11. Global Gene Therapy Products Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Gene Therapy Products Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Gene Therapy Products Sales (2016-2026) & (K Units)
Figure 14. Global Gene Therapy Products Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Gene Therapy Products Production Capacity (2016-2026) & (K Units)
Figure 16. Global Gene Therapy Products Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Gene Therapy Products Market Drivers
Figure 18. Gene Therapy Products Market Restraints
Figure 19. Gene Therapy Products Market Trends
Figure 20. Global Gene Therapy Products Sales Market Share by Manufacturer in 2020
Figure 21. Global Gene Therapy Products Revenue Market Share by Manufacturer in 2020
Figure 22. Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Gene Therapy Products Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Gene Therapy Products Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Gene Therapy Products Sales Market Share by Region (2016-2026)
Figure 26. Global Gene Therapy Products Revenue Market Share by Region (2016-2026)
Figure 27. North America Gene Therapy Products Revenue (2016-2026) & (USD Million)
Figure 28. Europe Gene Therapy Products Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Gene Therapy Products Revenue (2016-2026) & (USD Million)
Figure 30. South America Gene Therapy Products Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Gene Therapy Products Revenue (2016-2026) & (USD Million)
Figure 32. Global Gene Therapy Products Sales Market Share by Type (2016-2026)
Figure 33. Global Gene Therapy Products Revenue Market Share by Type (2016-2026)
Figure 34. Global Gene Therapy Products Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Gene Therapy Products Sales Market Share by Application (2016-2026)
Figure 36. Global Gene Therapy Products Revenue Market Share by Application (2016-2026)
Figure 37. Global Gene Therapy Products Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Gene Therapy Products Sales Market Share by Type (2016-2026)
Figure 39. North America Gene Therapy Products Sales Market Share by Application (2016-2026)
Figure 40. North America Gene Therapy Products Sales Market Share by Country (2016-2026)
Figure 41. North America Gene Therapy Products Revenue Market Share by Country (2016-2026)
Figure 42. United States Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Gene Therapy Products Sales Market Share by Type (2016-2026)
Figure 46. Europe Gene Therapy Products Sales Market Share by Application (2016-2026)
Figure 47. Europe Gene Therapy Products Sales Market Share by Country (2016-2026)
Figure 48. Europe Gene Therapy Products Revenue Market Share by Country (2016-2026)
Figure 49. Germany Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Gene Therapy Products Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Gene Therapy Products Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Gene Therapy Products Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Gene Therapy Products Revenue Market Share by Region (2016-2026)
Figure 58. China Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Gene Therapy Products Sales Market Share by Type (2016-2026)
Figure 65. South America Gene Therapy Products Sales Market Share by Application (2016-2026)
Figure 66. South America Gene Therapy Products Sales Market Share by Country (2016-2026)
Figure 67. South America Gene Therapy Products Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Gene Therapy Products Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Gene Therapy Products Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Gene Therapy Products Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Gene Therapy Products Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Gene Therapy Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の遺伝子治療市場予測（～2024年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…- 世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapy for CNS Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の遺伝子治療薬市場 2021：企業別、地域別、種類・用途別 The Gene Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の腫瘍学における遺伝子治療市場予測（～2024年）：企業別、地域別、種類・用途別 Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. Scope of the Report: The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a…
- 世界の遺伝子移植市場 2021：企業別、地域別、種類・用途別 The Gene Transplant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…